Cargando…

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors

OBJECTIVE: To investigate the efficacy of butylphthalide combined with edaravone in the treatment of acute ischemic stroke and the effect on serum inflammatory factors. METHODS: One hundred and sixty patients with acute ischemic stroke who attended the neurovascular intervention department of our ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Hong, Zhen, Li, Shaoquan, Xie, Songwang, Wang, Junyong, Wang, Jian, Liu, Yongchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113042/ https://www.ncbi.nlm.nih.gov/pubmed/37082457 http://dx.doi.org/10.1155/2023/9969437

Ejemplares similares

Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019)

Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Li, Keliang, et al.
Publicado: (2022)

Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: Hong, Zhen, et al.
Publicado: (2022)

Retracted: Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Healthcare Engineering, Journal of
Publicado: (2023)

Efficacy and association of hyperbaric oxygen therapy combined with butylphthalide and oxiracetam with serum levels of inflammatory markers in vascular cognitive impairment after acute ischemic stroke
por: Dong, Quanbin, et al.
Publicado: (2023)

Efficacy and safety of 3‐n‐butylphthalide combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion
por: Liu, Shuai, et al.
Publicado: (2022)

Efficacy of sequential N-butylphthalide therapy on psychiatric and behavioral functions in acute ischemic stroke
por: Yang, Le, et al.
Publicado: (2021)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Synthesis and radioprotective effects of novel hybrid compounds containing edaravone analogue and 3‐n‐butylphthalide ring‐opening derivatives
por: Li, Xuejiao, et al.
Publicado: (2021)

Effect of butylphthalide on new cerebral microbleeds in patients with acute ischemic stroke
por: Ding, Yunlong, et al.
Publicado: (2020)

A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke
por: Guo, Lin, et al.
Publicado: (2021)

L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization
por: Li, Fangfang, et al.
Publicado: (2018)

Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
por: Matsumoto, Shohei, et al.
Publicado: (2018)

Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
por: Yang, Di‐Xiao, et al.
Publicado: (2021)

A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
por: Sharma, Pawan, et al.
Publicado: (2011)

Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
por: Zhang, Ailing, et al.
Publicado: (2021)

Efficacy and safety of blood-activating herbs combined with edaravone in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Su, Zhuoyi, et al.
Publicado: (2022)

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018)

Efficacy of Guhong injection versus Butylphthalide and Sodium Chloride Injection for mild ischemic stroke: A multicenter controlled study
por: Zhang, Wei-Wei, et al.
Publicado: (2022)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
por: Wang, Huan, et al.
Publicado: (2022)

Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet
por: Lv, Junchao, et al.
Publicado: (2022)

Dl-3-n-butylphthalide inhibits neuroinflammation by stimulating foxp3 and Ki-67 in an ischemic stroke model
por: Liu, Xi, et al.
Publicado: (2021)

DL-3-n-butylphthalide Increases Collateriogenesis and Functional Recovery after Focal Ischemic Stroke in Mice
por: Wei, Zheng Zachory, et al.
Publicado: (2021)

Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke
por: Hu, Xiaohong, et al.
Publicado: (2023)

Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke
por: Nakase, Taizen, et al.
Publicado: (2011)

3-n-butylphthalide exerts neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke
por: Chen, Ningyuan, et al.
Publicado: (2018)

Protective multi-target effects of DL-3-n-butylphthalide combined with 3-methyl-1-phenyl-2-pyrazolin-5-one in mice with ischemic stroke
por: Guan, Yali, et al.
Publicado: (2021)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Safety and efficacy of edaravone for patients with acute stroke: A protocol for randomized clinical trial
por: Shan, Hailei, et al.
Publicado: (2021)

Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
por: Xu, Jie, et al.
Publicado: (2019)

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
por: Huang, Yuanxiang, et al.
Publicado: (2022)

Effects of Edaravone on Muscle Atrophy and Locomotor Function in Patients with Ischemic Stroke: A Randomized Controlled Pilot Study
por: Naritomi, Hiroaki, et al.
Publicado: (2012)

Effect of Butylphthalide combined with Oxiracetam on cognitive function, Intellectual recovery and serum inflammatory factors in patients with cognitive impairment after cerebral infarction
por: Jiang, Wenxin, et al.
Publicado: (2023)

Effectiveness of butylphthalide on cerebral autoregulation in ischemic stroke patients with large artery atherosclerosis (EBCAS study): A randomized, controlled, multicenter trial
por: Guo, Zhen-Ni, et al.
Publicado: (2023)

The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning
por: Zhang, Jiefang, et al.
Publicado: (2020)

Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?
por: Nair, Abhijit S.
Publicado: (2017)

Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency
por: Hu, Bo, et al.
Publicado: (2023)

Role of Butylphthalide in Immunity and Inflammation: Butylphthalide May Be a Potential Therapy for Anti-Inflammation and Immunoregulation
por: Zhang, Yiliu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ss3vub7i7ens20d2vba1fb7c8